Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients
Authors:
- 10 June 2012
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 29 (5) , 3070-3076
Abstract
RPS6KB1 (ribosomal protein S6 kinase, 70 kDa, polypeptide 1) plays a key role in regulating protein translation. The role of RPS6KB1 in HCC (hepatocellular carcinoma) has not been fully investigated. This study was undertaken to determine the clinicopathological features and prognostic value of RPS6KB1 in HCC. We examined RPS6KB1 expression in 30 paired liver cancer tissues and adjacent noncancerous tissues by reverse transcription real-time PCR and Western blotting. In addition, we analyzed RPS6KB1 expression in 87 HCC samples by immunohistochemistry. The expression of RPS6KB1 was significantly increased in cancer tissues. Clinicopathological analysis showed that the expression of RPS6KB1 was significantly correlated with tumor size, histopathologic classifications, and serum alpha-fetoprotein (AFP). Kaplan–Meier survival curves revealed that increased expression of RPS6KB1 correlated with poor prognosis of HCC patients. RPS6KB1 expression was an independent prognostic marker for overall survival of HCC patients by multivariate analysis. Our data suggest that RPS6KB1 may play an important role in the progression of HCC and could serve as a potential molecular target for HCC therapy.Keywords
This publication has 15 references indexed in Scilit:
- Overexpression of S6 Kinase 1 in Brain Tumours Is Associated with Induction of Hypoxia-Responsive Genes and Predicts Patients' SurvivalJournal of Oncology, 2012
- Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinomaMedical Oncology, 2011
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Bench to BedsideDigestive Diseases, 2011
- p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cellsOncogene, 2011
- Functions and regulation of the 70 kDa ribosomal S6 kinasesThe International Journal of Biochemistry & Cell Biology, 2011
- S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage responseThe EMBO Journal, 2010
- Hepatocellular Carcinoma: The Need for ProgressJournal of Clinical Oncology, 2005
- p53 Targets Chromatin Structure Alteration to Repress α-Fetoprotein Gene ExpressionJournal of Biological Chemistry, 2001
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Cloning and Characterization of p70S6KβDefines a Novel Family of p70 S6 KinasesBiochemical and Biophysical Research Communications, 1998